Taken together, these observations indicate that the cellular pathways leading to cell proliferation by NT and EGF are more complex in some cancer cell lines and that the ways to develop tools to decrease tumor growth remain more complicated than expected from previous studies. The gene discussed is EGF; the disease is neoplasm.